FDA Grants Breakthrough Status to Vision-Saving Drug for Optic Neuritis
Oculis (OCS) receives FDA Breakthrough Therapy Designation for Privosegtor, a promising treatment that could become the first neuroprotective therapy for optic neuritis and related eye conditions.